These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Marzocchi A; Piovaccari G; Manari A; Aurier E; Benassi A; Saia F; Casella G; Varani E; Santarelli A; Guastaroba P; Grilli R; Maresta A Am J Cardiol; 2005 Jun; 95(12):1409-14. PubMed ID: 15950561 [TBL] [Abstract][Full Text] [Related]
3. Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry. Costa M; Angiolillo DJ; Teirstein P; Gilmore P; Leon M; Moses J; Yakubov S; Carter A; Fischell T; Zenni M; Bass T J Invasive Cardiol; 2005 Aug; 17(8):396-8. PubMed ID: 16079441 [TBL] [Abstract][Full Text] [Related]
4. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524 [TBL] [Abstract][Full Text] [Related]
5. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis. Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962 [TBL] [Abstract][Full Text] [Related]
6. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397 [TBL] [Abstract][Full Text] [Related]
7. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. Orlic D; Bonizzoni E; Stankovic G; Airoldi F; Chieffo A; Corvaja N; Sangiorgi G; Ferraro M; Briguori C; Montorfano M; Carlino M; Colombo A J Am Coll Cardiol; 2004 Apr; 43(7):1154-60. PubMed ID: 15063422 [TBL] [Abstract][Full Text] [Related]
8. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group. Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S; J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837 [TBL] [Abstract][Full Text] [Related]
9. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281 [TBL] [Abstract][Full Text] [Related]
10. Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry. García-García HM; Daemen J; Kukreja N; Tanimoto S; van Mieghem CA; van der Ent M; van Domburg RT; Serruys PW Catheter Cardiovasc Interv; 2007 Nov; 70(5):635-9. PubMed ID: 17960629 [TBL] [Abstract][Full Text] [Related]
11. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2. Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Yamaji K; Ando K; Shizuta S; Shiomi H; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Tamura T; Shirotani M; Miki S; Matsuda M; Takahashi M; Ishii K; Tanaka M; Aoyama T; Doi O; Hattori R; Kato M; Suwa S; Takizawa A; Takatsu Y; Shinoda E; Eizawa H; Takeda T; Lee JD; Inoko M; Ogawa H; Hamasaki S; Horie M; Nohara R; Kambara H; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T; Circ Cardiovasc Interv; 2014 Apr; 7(2):168-79. PubMed ID: 24550439 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery. Hoye A; Lemos PA; Arampatzis CA; Saia F; Tanabe K; Degertekin M; Hofma S; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW Coron Artery Dis; 2004 May; 15(3):171-5. PubMed ID: 15096998 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance. Seung KB; Kim YH; Park DW; Lee BK; Lee CW; Hong MK; Kim PJ; Chung WS; Tahk SJ; Park SW; Park SJ J Am Coll Cardiol; 2005 Sep; 46(5):787-92. PubMed ID: 16139126 [TBL] [Abstract][Full Text] [Related]
14. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G; J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219 [TBL] [Abstract][Full Text] [Related]
15. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world. Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297 [TBL] [Abstract][Full Text] [Related]
16. Sirolimus-eluting stent in chronic total occlusion: the SICTO study. Lotan C; Almagor Y; Kuiper K; Suttorp MJ; Wijns W J Interv Cardiol; 2006 Aug; 19(4):307-12. PubMed ID: 16881976 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry. Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY; Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617 [TBL] [Abstract][Full Text] [Related]